Korean J Gastroenterol.  2011 Jul;58(1):61-63. 10.4166/kjg.2011.58.1.61.

The Safety of Thiopurine Treatment in Pregnant Women with Inflammatory Bowel Disease

• Ye BD

• KMID: 1792818
• DOI: http://doi.org/10.4166/kjg.2011.58.1.61

Abstract

No abstract available.

Reference

References

1. Githens JH, Rosenkrantz JG, Tunnock SM. Teratogenic effects of azathioprine (Imuran). J Pediatr. 1965; 66:959–961.

2. Rosenkrantz JG, Githens JH, Cox SM, Kellum DL. Azathioprine (Imuran) and pregnancy. Am J Obstet Gynecol. 1967; 97:387–394.

3. Platzek T, Bochert G. Dose-response relationship of ter-atogenicity and prenatal-toxic risk estimation of 6-mercaptopur-ine riboside in mice. Teratog Carcinog Mutagen. 1996; 16:169–181.

4. Polifka JE, Friedman JM. Teratogen update: azathioprine and 6-mercaptopurine. Teratology. 2002; 65:240–261.

5. N⊘rgård B, Pedersen L, Christensen LA, S⊘rensen HT. Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study. Am J Gastroenterol. 2007; 102:1406–1413.

6. Coelho J, Beaugerie L, Colombel JF, et al. Pregnancy outcome in patients with inflammatory bowel disease treated with thio-purines: cohort from the CESAME Study. Gut. 2011; 60:198–203.

7. van der Woude CJ, Kolacek S, Dotan I, et al. European evi-denced-based consensus on reproduction in inflammatory bowel disease. J Crohns Colitis. 2010; 4:493–510.

8. Cornish J, Tan E, Teare J, et al. A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut. 2007; 56:830–837.

9. Mahadevan U, Sandborn WJ, Li DK, Hakimian S, Kane S, Corley DA. Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology. 2007; 133:1106–1112.

10. Goldstein LH, Dolinsky G, Greenberg R, et al. Pregnancy outcome of women exposed to azathioprine during pregnancy. Birth Defects Res A Clin Mol Teratol. 2007; 79:696–701.

11. De Vigan C, Khoshnood B, Lhomme A, Vodovar V, Goujard J, Goffinet F. Prevalence and prenatal diagnosis of congenital malformations in the Parisian population: twenty years of surveillance by the Paris Registry of congenital malformations. J Gynecol Obstet Biol Reprod (Paris). 2005; 34:8–16.